Short Interest in Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Increases By 344.2%

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 23,100 shares, a growth of 344.2% from the June 15th total of 5,200 shares. Based on an average daily volume of 252,900 shares, the days-to-cover ratio is presently 0.1 days.

Fresenius SE & Co. KGaA Stock Performance

Shares of FSNUY stock traded up $0.09 on Thursday, hitting $8.07. The stock had a trading volume of 63,022 shares, compared to its average volume of 50,177. The firm has a market capitalization of $18.03 billion, a price-to-earnings ratio of 10.77 and a beta of 1.05. The stock’s 50 day moving average is $7.81 and its 200-day moving average is $7.36. Fresenius SE & Co. KGaA has a 52-week low of $6.33 and a 52-week high of $8.44.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last announced its earnings results on Wednesday, May 8th. The company reported $0.20 earnings per share for the quarter. The firm had revenue of $6.19 billion during the quarter. Equities analysts expect that Fresenius SE & Co. KGaA will post 0.81 earnings per share for the current year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.